Upgrade to SI Premium - Free Trial

Quantum BioPharma gets FDA clearance for Lucid-MS phase 2 MS trial

August 10, 2026 7:00 AM
Quantum BioPharma Ltd. (NASDAQ: QNTM, CSE: QNTM) announced that the U.S. Food and Drug Administration has cleared the company's Investigational ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

FDA